INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO

Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

1997 • 4,504 citations

The Biology of Vascular Endothelial Growth Factor

1997 • 4,359 citations

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1995 • 2,308 citations

Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells

1998 • 2,282 citations

TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue

1991 • 1,814 citations

Cancer statistics, 1996

1996 • 1,807 citations

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

1993 • 1,646 citations

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

1994 • 1,460 citations

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1997 • 1,411 citations

The Vascular Endothelial Growth Factor Family: Identification of a Fourth Molecular Species and Characterization of Alternative Splicing of RNA

1991 • 1,375 citations

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

1994 • 1,322 citations

The Biology of Vascular Endothelial Growth Factor

1997 • 1,203 citations

PRIMARY RESPONSE GENES INDUCED BY GROWTH FACTORS AND TUMOR PROMOTERS

1991 • 1,078 citations

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

1998 • 933 citations

Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)

1998 • 773 citations

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1997 • 734 citations

Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells

1997 • 673 citations

NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

1998 • 439 citations

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

1996 • 421 citations

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

1993 • 348 citations

Implication of cell kinetic changes during the progression of human prostatic cancer.

1995 • 345 citations

Identification of a phorbol ester-repressible v-src-inducible gene.

1989 • 322 citations

Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs

1992 • 313 citations

Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2

1998 • 257 citations

Effect of Dietary Fat on Human Breast Cancer Growth and Lung Metastasis in Nude Mice

1991 • 116 citations

Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.

1997 • 111 citations

Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.

1990 • 82 citations

Aspirin-like molecules that covalently inactivate cyclooxygenase-2

1999 • 60 citations

Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors

1997 • 19 citations

NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down regulation bcl-2 expression in LNCaP cells

1998 • 3 citations